mouse anti human tlr10 h00081793 m01 (Novus Biologicals)
Structured Review

Mouse Anti Human Tlr10 H00081793 M01, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 7 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse anti human tlr10 h00081793 m01/product/Novus Biologicals
Average 93 stars, based on 7 article reviews
Images
1) Product Images from "TLR10 Senses HIV-1 Proteins and Significantly Enhances HIV-1 Infection"
Article Title: TLR10 Senses HIV-1 Proteins and Significantly Enhances HIV-1 Infection
Journal: Frontiers in Immunology
doi: 10.3389/fimmu.2019.00482
Figure Legend Snippet: Flow cytometry analyses of TLR1, TLR2, and TLR10 expression in the two major types of primary BM cells obtained from HIV-1 uninfected women at 3 months post-partum. Leucocytes were gated with CD45-PerCP-Cy5.5 and CD14-V450 whereas the epithelial cells were gated with MUC1-PE-Cy7 and CD45-. The antibodies TLR1-APC TLR2-APC and TLR10-PE were separately used to detect TLR1, TLR2, and TLR10 in CD14 + -CD45 + -MUC1 − and MUC1 + -CD45 − cell types to differentiate the two major constituents of BM. Representative images are shown with TLR1, TLR2, and TLR10 expression depicted as percentages on right corner of each image.
Techniques Used: Flow Cytometry, Expressing
Figure Legend Snippet: Significantly elevated expression level of TLR1 and TLR10 in HIV-1 infected human primary BM cells. Expression of TLR1 and TLR10 as measured by qRT-PCR with the mRNA extracted from primary BM cells collected from HIV-1 negative Hamilton, Canada women (HIV-N Hamilton) and Nigerian HIV-1 negative (HIV-N) and HIV-1 positive (HIV-P) women. TLR1 expression is shown on right ( p = 0.0006) whereas TLR10 expression is shown on left ( p < 0.0001).
Techniques Used: Expressing, Infection, Quantitative RT-PCR
Figure Legend Snippet: Overexpression or siRNA mediated knockdown of TLR10 significantly alters HIV-1 infection and integration (A) HIV-1 infection was significantly enhanced in HIV-1 reporter TZMbl cells transiently overexpressing TLR10 alone and co-transfected with TLR2 or TLR1 expression plasmids by measuring luciferase activity in relative light units (RLU). (B) HIV-1 integration was significantly increased in stable TZMbl reporter cells overexpressing TLR10, TLR2, and TLR1. TZMbl, TLR2- stable, and TLR10-stable cells were used for co-transfection with plasmids: empty vector, TLR2, TLR10, and TLR1 vector, TLR10 and TLR1 vector, and TLR2 and TLR1 vector. Proviral DNA (DNA pol) was detected by PCR and normalized to the 18S rRNA gene. (C) Proviral DNA was obviously decreased in macrophages with TLR10 knocked down prior to HIV-1 infection. T20: Enfuvirtide, an HIV-1 fusion inhibitor used as a negative control. Data set is representative of three different experiments completed in triplicate (Statistic marks in the plots: * p < 0.05 , ** p < 0.01 for Mann Whitney t -tests, each group compared to the vector group in A and B, or to the control group in C; pair comparison ∧, # in B, respectively).
Techniques Used: Over Expression, Knockdown, Infection, Transfection, Expressing, Luciferase, Activity Assay, Cotransfection, Plasmid Preparation, Negative Control, MANN-WHITNEY, Control, Comparison
Figure Legend Snippet: Effects of PAMPs and HIV-1 on the level of TLR expression in cell cultures. (A) qRT-PCR of TLR10, TLR2, and TLR1 mRNA from MCF-10A cells treated with TLR2 PAMP Pam3CSK4, TLR4 PAMP LPS, TLR7/TLR8 PAMP ssRNA40, and cell-free HIV-1 BAL. (B) q-RT-PCR in THP-1 cells. (C) qRT-PCR in primary BM cells. Data set is representative of three different experiments completed in triplicate. Statistic marks: * p < 0.05 , ** p < 0.01 for the Mann-Whitney t -tests, each group compared to medium-treated group (Medium).
Techniques Used: Expressing, Quantitative RT-PCR, Reverse Transcription Polymerase Chain Reaction, MANN-WHITNEY
Figure Legend Snippet: Effects of HIV-1 proteins on TLR expression and cellular responses. (A) MCF-10A cells were treated with Pam3CSK4 and the HIV-1 structural proteins: p17, p24, gp41, and gp120. Cellular TLR10, TLR2, and TLR1 mRNAs were analyzed by qRT-PCR. (B) IL-8 production in cell culture supernatants in the presence of different concentrations of Pam3CSK4 and HIV-1 proteins were analyzed by ELISA. (C) The expression of TLR mRNAs analyzed by qRT-PCR in THP-1 cells treated with Pam3CSK4 and the HIV-1 structural proteins: p17, p24, and gp41. (D) IL-8 production in THP-1 cell culture supernatants in the presence of different concentrations of Pam3CSK4 and HIV-1 proteins was analyzed by ELISA. Data set is representative of three different experiments completed in triplicate. Statistic marks: * p < 0.05 , ** p < 0.01 for the Mann-Whitney t -tests, each group was compared to the medium-treated group (Medium).
Techniques Used: Expressing, Quantitative RT-PCR, Cell Culture, Enzyme-linked Immunosorbent Assay, MANN-WHITNEY
Figure Legend Snippet: HIV-1 proteins, p17 and gp41 elicit cellular responses through sensing TLR10, TLR2, and TLR1. IL-8 production stimulated by Pam3CSK4, p17, p24, and gp41 was greatly suppressed in THP-1 cells knocked-down of TLR10 with specific siRNA (A) and THP-1 cells neutralized with anti-TLR10 antibody (B) . (C) IL-8 stimulated by Pam3CSK4 and gp41 was reduced in MCF-10A cells neutralized with an anti-TLR10 antibody. (D) Primary BM cells displayed a significant decrease in IL-8 production induced by HIV-1 gp41 following neutralization with an anti-TLR10 antibody. Data set is representative of three different experiments completed in triplicate. Statistic marks: * p < 0.05 ; ** p < 0.01 for Mann Whitney t -tests, with each group compared to the medium treated group (Medium).
Techniques Used: Neutralization, MANN-WHITNEY
Figure Legend Snippet: siRNA mediated knockdown or antibody mediated blocking of TLR10 inhibits NF-κBα activation induced by HIV-1 proteins (A) anti-TLR10 antibody decreased gp41 induced P-IκBα by half in MCF-10A cells. (B) TLR10 siRNA ablated the induction of P-IκBα by gp41 in THP-1 cells.
Techniques Used: Knockdown, Blocking Assay, Activation Assay
